JP2022524435A5 - - Google Patents

Info

Publication number
JP2022524435A5
JP2022524435A5 JP2021554697A JP2021554697A JP2022524435A5 JP 2022524435 A5 JP2022524435 A5 JP 2022524435A5 JP 2021554697 A JP2021554697 A JP 2021554697A JP 2021554697 A JP2021554697 A JP 2021554697A JP 2022524435 A5 JP2022524435 A5 JP 2022524435A5
Authority
JP
Japan
Prior art keywords
rna
induced
modifications
target site
donor dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021554697A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022524435A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/022056 external-priority patent/WO2020185867A1/en
Publication of JP2022524435A publication Critical patent/JP2022524435A/ja
Publication of JP2022524435A5 publication Critical patent/JP2022524435A5/ja
Priority to JP2024116841A priority Critical patent/JP2024133347A/ja
Pending legal-status Critical Current

Links

JP2021554697A 2019-03-11 2020-03-11 Rna誘導型エンドヌクレアーゼを使用したdna構築物の組み込みプロセスの向上 Pending JP2022524435A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024116841A JP2024133347A (ja) 2019-03-11 2024-07-22 Rna誘導型エンドヌクレアーゼを使用したdna構築物の組み込みプロセスの向上

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962816836P 2019-03-11 2019-03-11
US62/816,836 2019-03-11
US201962901735P 2019-09-17 2019-09-17
US62/901,735 2019-09-17
PCT/US2020/022056 WO2020185867A1 (en) 2019-03-11 2020-03-11 Improved process for integration of dna constructs using rna-guided endonucleases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024116841A Division JP2024133347A (ja) 2019-03-11 2024-07-22 Rna誘導型エンドヌクレアーゼを使用したdna構築物の組み込みプロセスの向上

Publications (2)

Publication Number Publication Date
JP2022524435A JP2022524435A (ja) 2022-05-02
JP2022524435A5 true JP2022524435A5 (cg-RX-API-DMAC7.html) 2023-03-15

Family

ID=70190148

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021554697A Pending JP2022524435A (ja) 2019-03-11 2020-03-11 Rna誘導型エンドヌクレアーゼを使用したdna構築物の組み込みプロセスの向上
JP2024116841A Pending JP2024133347A (ja) 2019-03-11 2024-07-22 Rna誘導型エンドヌクレアーゼを使用したdna構築物の組み込みプロセスの向上

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024116841A Pending JP2024133347A (ja) 2019-03-11 2024-07-22 Rna誘導型エンドヌクレアーゼを使用したdna構築物の組み込みプロセスの向上

Country Status (11)

Country Link
US (1) US20220145333A1 (cg-RX-API-DMAC7.html)
EP (1) EP3938510A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022524435A (cg-RX-API-DMAC7.html)
KR (1) KR20210149734A (cg-RX-API-DMAC7.html)
CN (1) CN113825834A (cg-RX-API-DMAC7.html)
AU (1) AU2020239050A1 (cg-RX-API-DMAC7.html)
CA (1) CA3133226A1 (cg-RX-API-DMAC7.html)
IL (1) IL286244A (cg-RX-API-DMAC7.html)
MX (1) MX2021010938A (cg-RX-API-DMAC7.html)
SG (1) SG11202109972QA (cg-RX-API-DMAC7.html)
WO (1) WO2020185867A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4139345A1 (en) 2020-04-24 2023-03-01 Sorrento Therapeutics, Inc. Memory dimeric antigen receptors
WO2022015956A1 (en) 2020-07-15 2022-01-20 Sorrento Therapeutics, Inc. Improved process for dna integration using rna-guided endonucleases
WO2022061115A1 (en) * 2020-09-18 2022-03-24 Vor Biopharma Inc. Compositions and methods for cd7 modification
JP7877351B2 (ja) * 2021-03-19 2026-06-22 メタゲノミ セラピューティクス,インク. Cas酵素を用いたマルチプレックス編集
US20240182890A1 (en) * 2021-04-07 2024-06-06 Astrazeneca Ab Compositions and methods for site-specific modification
CA3223311A1 (en) * 2021-06-18 2022-12-22 Andrea BARGHETTI Compositions and methods for targeting, editing or modifying human genes
WO2023097236A1 (en) * 2021-11-24 2023-06-01 The Rockefeller University Compositions and methods for generating immunoglobulin knock-in mice
CN115851591A (zh) * 2022-11-30 2023-03-28 山东博群生物技术有限公司 细胞因子刺激剂及诱导淋巴细胞产生细胞因子的方法
WO2026020171A2 (en) 2024-07-19 2026-01-22 Aera Therapeutics, Inc. Chimeric antigen receptor constructs

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5489677A (en) 1990-07-27 1996-02-06 Isis Pharmaceuticals, Inc. Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
US6555674B2 (en) 2000-08-09 2003-04-29 Nsgene A/S JeT promoter
CA2720903C (en) * 2008-04-14 2019-01-15 Sangamo Biosciences, Inc. Linear donor constructs for targeted integration
ES2728782T3 (es) 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
CA2932439A1 (en) 2013-12-12 2015-06-18 The Broad Institute, Inc. Crispr-cas systems and methods for altering expression of gene products, structural information and inducible modular cas enzymes
CN113930455A (zh) * 2014-10-09 2022-01-14 生命技术公司 Crispr寡核苷酸和基因剪辑
CA2986310A1 (en) * 2015-05-11 2016-11-17 Editas Medicine, Inc. Optimized crispr/cas9 systems and methods for gene editing in stem cells
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
JP7011590B2 (ja) * 2015-10-12 2022-02-10 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 細胞内での遺伝子組換えおよび相同組換えの増加のための保護dna鋳型および使用方法
JP2019532644A (ja) 2016-09-30 2019-11-14 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Rna誘導型核酸修飾酵素及びその使用方法
KR20190130608A (ko) * 2017-03-22 2019-11-22 노파르티스 아게 면역종양학을 위한 조성물 및 방법
MY200418A (en) * 2017-06-15 2023-12-25 Univ California Targeted non-viral dna insertions
JP2020530997A (ja) * 2017-08-08 2020-11-05 サンガモ セラピューティクス, インコーポレイテッド キメラ抗原受容体媒介性細胞標的化
SG11202008568WA (en) 2018-03-09 2020-10-29 Sorrento Therapeutics Inc Dimeric antigen receptors (dar)

Similar Documents

Publication Publication Date Title
JP2022521787A5 (cg-RX-API-DMAC7.html)
JP2024174943A5 (cg-RX-API-DMAC7.html)
US11884915B2 (en) Guide RNAs with chemical modification for prime editing
JP2022523302A (ja) アッシャー症候群の処置のためのrna編集オリゴヌクレオチド
RU2017130143A (ru) Гибридные днк/рнк-полинукдеотиды crispr и способы
JP2018138054A5 (cg-RX-API-DMAC7.html)
US20120015821A1 (en) Methods of Generating Gene Specific Libraries
CN107787367A (zh) 用于crispr/cas介导的基因调控的化学修饰的引导rna
JP2023504264A5 (cg-RX-API-DMAC7.html)
EP3277816A1 (en) Crispr/cas-related methods and compositions for treating duchenne muscular dystrophy and becker muscular dystrophy
JP2020524998A5 (cg-RX-API-DMAC7.html)
EP3344771A1 (en) Compounds and methods for crispr/cas-based genome editing by homologous recombination
CA2968336A1 (en) Construct for site directed editing of an adenosine nucleotide in target rna
WO2016094845A3 (en) Compositions and methods for editing nucleic acids in cells utilizing oligonucleotides
CA3025523A1 (en) Peptides and nanoparticles for intracellular delivery of genome-editing molecules
CN102203273A (zh) 生成基因特异性的文库的方法
WO2015089053A1 (en) Long nucleic acid sequences containing variable regions
RU2020100919A (ru) СПОСОБ НОКАУТИРОВАНИЯ ГЕНА-МИШЕНИ В T-КЛЕТКЕ IN VITRO И crRNA, ПРИМЕНЯЕМАЯ В ДАННОМ СПОСОБЕ
CA3133226A1 (en) Improved process for integration of dna constructs using rna-guided endonucleases
JP2024533448A (ja) 化学修飾を有するガイドrnaを使用する方法
JP7762651B2 (ja) 修飾二重鎖ドナー鋳型
Layden et al. Alternate trans splicing in Trypanosoma equiperdum: implications for splice site selection
US12522857B2 (en) Compositions and methods of targeted nucleic acid enrichment by loop adapter protection and exonuclease digestion
WO2023015205A2 (en) Compositions and methods for improved gene editing
Moss History and development of molecular biology